Article
Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients.
Gene - 15 Mar 2014
Tavira Beatriz, Gómez Juan, Díaz-Corte Carmen, Llobet Laura, Ruiz-Pesini Eduardo, Ortega Francisco, Coto Eliecer
Abstract excerpt
BACKGROUND AND AIMS: Tacrolimus (Tac) is an immunosuppressive drug widely used to avoid organ rejection. New-onset diabetes after transplantation (NODAT) is a major complication among transplanted patients who receive Tac. The increased risk for NODAT could be partly mediated by the effect of Tac on mitochondria from pancreatic beta-cells. Common and rare mitochondrial DNA variants have been linked to the risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
